Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trialMartin Dennis(Tissue Regeneration Systems (United States))The LancetDecember 5, 201810.1016/s0140-6736(18)32823-xCited by 285SaveCiteExport RISWatch citationsRelated PapersThe benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial|The Lancet|2012|1.2kStroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden|Neurology|2014|1kEnlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease|Stroke|2010|913Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?|Stroke|2003|629